RxDoctor Payments Data

Kelli Nissen

Gerontology · Las Vegas, NVNPI 1952093692

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Biotronik NRO, Inc. accounts for 60.9% of it on its own, with 23 other manufacturers making up the rest. Among gerontology clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,060in general payments, 2019–2025

Across 113 payments — averaging $53.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotronik NRO, Inc.$4K
  • AbbVie$497
  • Boston Scientific$371
  • Biogen$184
  • Livanova USA, Inc.$166
  • SK Life Science, Inc.$145
  • plus $1K from 18 others

What the payments were for

  • Speaking & faculty fees$2,87547%
  • Travel & lodging$180%
  • Food & beverage$3,16852%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,060 in reported general payments places this provider in the 90th percentile of 72 gerontology providers in Nevada.

See all gerontology providers in Nevada

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant17$17,877
QuliptaAtogepant13$14,015
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen93$2,651
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen58$1,719
Oxycodone Hcl74$1,668
Lidocaine17$1,566
Pregabalin44$1,333
Gabapentin72$777
Levetiracetam21$533
Primidone35$496
Donepezil Hcl76$453
Carbamazepine14$435
Cyclobenzaprine Hcl23$357
Memantine Hcl40$348
Tramadol Hcl41$286

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta$497$31,89230 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 72 gerontology providers in Nevada.

Other gerontology in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →